Avanos Medical Appoints New Director to Bolster Governance

Avanos Medical (AVNS) just unveiled an update.

Avanos Medical, Inc. has enhanced its Board of Directors with the appointment of Indrani Franchini, effective July 1, 2024. Franchini, whose selection was independent of any external agreements, will also contribute to the Audit and Compliance Committees. She will receive a comprehensive compensation package, including cash retainers for board and committee services and restricted share units totaling $279,000 annually, with reimbursements for meeting attendance expenses. This strategic move has been publicly announced, aiming to strengthen the company’s governance and oversight.

For a thorough assessment of AVNS stock, go to TipRanks’ Stock Analysis page.